Search

everythinglearnresearchcommunity

for

Search:↓

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

Finasteride reduces scalp DHT levels, potentially treating male pattern baldness.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Researchers developed a method to detect hormone-blocking drugs in wastewater and found them in Beijing's sewage, suggesting they can survive sewage treatment.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

Higher BMI links to worse hair loss in Taiwanese men.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Eating paradise nuts led to selenium poisoning, causing nausea, hair loss, and other symptoms in two women.

Testosterone can slow down hair growth when combined with certain cells from bald scalps, and this effect can be blocked by an androgen receptor blocker.

Using finasteride with TIP extends time off period for prostate cancer patients.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Combination therapy improves hair growth in advanced hair loss.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

Menopause can cause skin issues, and seeing a dermatologist helps.

Finasteride can cause muscle pain and high creatine kinase levels, but stopping the medication may resolve symptoms.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

Oral dutasteride works better for hair loss, but has more sexual side effects; intralesional dutasteride is a possible alternative.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Dihydrotestosterone changes some hormone-related gene expressions in rat pituitary glands but doesn't affect the estrous cycle.

Dutasteride shows promise as a potential treatment for Parkinson's disease.

Energy healing treatment improved flutamide's solubility and stability, potentially enhancing its effectiveness for prostate cancer.

Celery extract and candlenut oil effectively and safely boost hair growth.